CN111455016A - 长寿家族的肠道微生态图谱的建立及其在增龄健康领域的应用 - Google Patents
长寿家族的肠道微生态图谱的建立及其在增龄健康领域的应用 Download PDFInfo
- Publication number
- CN111455016A CN111455016A CN202010191005.2A CN202010191005A CN111455016A CN 111455016 A CN111455016 A CN 111455016A CN 202010191005 A CN202010191005 A CN 202010191005A CN 111455016 A CN111455016 A CN 111455016A
- Authority
- CN
- China
- Prior art keywords
- prevotella
- porphyromonas
- bifidobacterium adolescentis
- intestinal
- parabacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 14
- 230000000968 intestinal effect Effects 0.000 title abstract description 17
- 230000032683 aging Effects 0.000 title abstract description 7
- 241000605861 Prevotella Species 0.000 claims abstract description 27
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims abstract description 25
- 241000605894 Porphyromonas Species 0.000 claims abstract description 22
- 244000005700 microbiome Species 0.000 claims abstract description 22
- 230000002550 fecal effect Effects 0.000 claims abstract description 19
- 230000003750 conditioning effect Effects 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 5
- 235000015097 nutrients Nutrition 0.000 claims abstract description 5
- 238000002054 transplantation Methods 0.000 claims abstract description 4
- 241000379991 Anaerococcus Species 0.000 claims description 16
- 230000000813 microbial effect Effects 0.000 claims description 9
- 230000007413 intestinal health Effects 0.000 claims description 7
- 239000006041 probiotic Substances 0.000 claims description 7
- 235000018291 probiotics Nutrition 0.000 claims description 7
- 230000009758 senescence Effects 0.000 claims description 6
- 230000003827 upregulation Effects 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 241000193403 Clostridium Species 0.000 claims description 3
- 241001057811 Paracoccus <mealybug> Species 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 210000003608 fece Anatomy 0.000 claims description 3
- 230000008621 organismal health Effects 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 abstract description 15
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 10
- 238000011160 research Methods 0.000 abstract description 7
- 230000007246 mechanism Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 230000003993 interaction Effects 0.000 abstract description 2
- 239000002207 metabolite Substances 0.000 abstract description 2
- 239000007787 solid Substances 0.000 abstract description 2
- 241001655514 Anaerobacterium Species 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000006872 improvement Effects 0.000 description 6
- 241000160321 Parabacteroides Species 0.000 description 5
- 241000692843 Porphyromonadaceae Species 0.000 description 4
- 241001608472 Bifidobacterium longum Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 241001013579 Anaerotruncus Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 229940009291 bifidobacterium longum Drugs 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000013145 classification model Methods 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010191005.2A CN111455016A (zh) | 2020-03-18 | 2020-03-18 | 长寿家族的肠道微生态图谱的建立及其在增龄健康领域的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010191005.2A CN111455016A (zh) | 2020-03-18 | 2020-03-18 | 长寿家族的肠道微生态图谱的建立及其在增龄健康领域的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111455016A true CN111455016A (zh) | 2020-07-28 |
Family
ID=71676697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010191005.2A Pending CN111455016A (zh) | 2020-03-18 | 2020-03-18 | 长寿家族的肠道微生态图谱的建立及其在增龄健康领域的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111455016A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112410443A (zh) * | 2020-10-21 | 2021-02-26 | 上海市第十人民医院 | 一种用于鉴别高龄个体的生物种群标志物及其获得方法和应用 |
CN113186310A (zh) * | 2021-04-23 | 2021-07-30 | 复旦大学附属中山医院 | 一种通过肠道菌群相对丰度预测健康性老化的方法 |
WO2023276475A1 (ja) * | 2021-06-30 | 2023-01-05 | アニコム ホールディングス株式会社 | 死亡予測システム及び死亡予測方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102743420A (zh) * | 2012-06-06 | 2012-10-24 | 上海交通大学 | 改善肠道菌群结构的方法及应用 |
CN104120092A (zh) * | 2013-04-26 | 2014-10-29 | 任发政 | 青春双歧杆菌及其应用以及功能食品组合物及其制备方法 |
CN104204810A (zh) * | 2012-03-22 | 2014-12-10 | 雀巢产品技术援助有限公司 | 苯乙酰谷氨酰胺作为健康性老化的生物标志物 |
CN105105115A (zh) * | 2015-08-21 | 2015-12-02 | 暨南大学 | 针对abo血型人群的益生菌复合物及其方法与应用 |
CN105603066A (zh) * | 2016-01-13 | 2016-05-25 | 金锋 | 精神障碍的肠道微生物标志物及其应用 |
US20160339064A1 (en) * | 2011-02-04 | 2016-11-24 | Katherine Rose Kovarik | Method and System for Treating Cancer Cachexia |
CN107699517A (zh) * | 2017-10-17 | 2018-02-16 | 无限极(中国)有限公司 | 一种青春双歧杆菌及其用途 |
CN110087530A (zh) * | 2016-12-07 | 2019-08-02 | 普罗根尼蒂公司 | 胃肠道检测方法、装置和系统 |
WO2019209753A1 (en) * | 2018-04-22 | 2019-10-31 | Viome, Inc. | Systems and methods for inferring scores for health metrics |
-
2020
- 2020-03-18 CN CN202010191005.2A patent/CN111455016A/zh active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160339064A1 (en) * | 2011-02-04 | 2016-11-24 | Katherine Rose Kovarik | Method and System for Treating Cancer Cachexia |
CN104204810A (zh) * | 2012-03-22 | 2014-12-10 | 雀巢产品技术援助有限公司 | 苯乙酰谷氨酰胺作为健康性老化的生物标志物 |
CN102743420A (zh) * | 2012-06-06 | 2012-10-24 | 上海交通大学 | 改善肠道菌群结构的方法及应用 |
CN104120092A (zh) * | 2013-04-26 | 2014-10-29 | 任发政 | 青春双歧杆菌及其应用以及功能食品组合物及其制备方法 |
CN105105115A (zh) * | 2015-08-21 | 2015-12-02 | 暨南大学 | 针对abo血型人群的益生菌复合物及其方法与应用 |
CN105603066A (zh) * | 2016-01-13 | 2016-05-25 | 金锋 | 精神障碍的肠道微生物标志物及其应用 |
CN110087530A (zh) * | 2016-12-07 | 2019-08-02 | 普罗根尼蒂公司 | 胃肠道检测方法、装置和系统 |
CN107699517A (zh) * | 2017-10-17 | 2018-02-16 | 无限极(中国)有限公司 | 一种青春双歧杆菌及其用途 |
WO2019209753A1 (en) * | 2018-04-22 | 2019-10-31 | Viome, Inc. | Systems and methods for inferring scores for health metrics |
Non-Patent Citations (4)
Title |
---|
IAN B JEFFERY等: "Composition and temporal stability of the gut microbiota in older persons", 《THE ISME JOURNAL》 * |
SE-HOON PARK等: "Comparative analysis of gut microbiota in elderly people of urbanized towns and longevity villages", 《BMC MICROBIOLOGY》 * |
TANYA YATSUNENKO等: "Human gut microbiome viewed across age and geography", 《NATURE》 * |
李忠元等: "健康长寿老人肠道双歧杆菌鉴定", 《中国微生态学杂志》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112410443A (zh) * | 2020-10-21 | 2021-02-26 | 上海市第十人民医院 | 一种用于鉴别高龄个体的生物种群标志物及其获得方法和应用 |
CN112410443B (zh) * | 2020-10-21 | 2023-08-25 | 上海市第十人民医院 | 一种用于鉴别高龄个体的生物种群标志物及其获得方法和应用 |
CN113186310A (zh) * | 2021-04-23 | 2021-07-30 | 复旦大学附属中山医院 | 一种通过肠道菌群相对丰度预测健康性老化的方法 |
CN113186310B (zh) * | 2021-04-23 | 2022-12-13 | 复旦大学附属中山医院 | 一种通过肠道菌群相对丰度预测健康性老化的方法 |
WO2023276475A1 (ja) * | 2021-06-30 | 2023-01-05 | アニコム ホールディングス株式会社 | 死亡予測システム及び死亡予測方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tett et al. | Prevotella diversity, niches and interactions with the human host | |
Andoh et al. | Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease | |
Younge et al. | Early-life skin microbiota in hospitalized preterm and full-term infants | |
Chen et al. | Alterations in the gut microbiotas of children with food sensitization in early life | |
Lloyd-Price et al. | The healthy human microbiome | |
CN111455016A (zh) | 长寿家族的肠道微生态图谱的建立及其在增龄健康领域的应用 | |
Kirk et al. | Optimized cultivation of Campylobacter concisus from gut mucosal biopsies in inflammatory bowel disease | |
Zhang et al. | Comparative analysis of gut microbiota changes in Père David's deer populations in Beijing Milu Park and Shishou, Hubei Province in China | |
Vincent et al. | Excretion of host DNA in feces is associated with risk of Clostridium difficile infection | |
Lin et al. | Alterations in the fecal microbiota of patients with spinal cord injury | |
Khan et al. | A generalist lifestyle allows rare Gardnerella spp. to persist at low levels in the vaginal microbiome | |
Damaceno et al. | Isolation and identification of potential probiotic bacteria from human milk | |
Dumitru et al. | Evaluation of non-encapsulated and microencapsulated lactic acid bacteria | |
Delgado et al. | Interindividual differences in microbial counts and biochemical-associated variables in the feces of healthy Spanish adults | |
Clavel et al. | Isolation of bacteria from mouse caecal samples and description of Bacteroides sartorii sp. nov | |
Edwards et al. | A systematic review of breast milk microbiota composition and the evidence for transfer to and colonisation of the infant gut | |
KR20210129953A (ko) | 대사성 질환과 안질환의 예방 및 건강 유지를 위한 장내 미생물 검사 기반 맞춤형 프리바이오틱스 또는 프로바이오틱스 정보 제공방법 | |
CN109652570A (zh) | 微生物在鉴别和/或区分不同种族个体中的应用 | |
CN111458490B (zh) | 长寿家族的肠道代谢图谱的建立及其在增龄健康领域的应用 | |
van der Sluis et al. | The effect of surgical fecal stream diversion of the healthy colon on the colonic microbiota | |
Katouli et al. | Evaluation of the Phene Plate generalized microplate for metabolic fingerprinting and for measuring fermentative capacity of mixed bacterial populations | |
Gao et al. | Effects of Bacillus subtilis BSNK-5-Fermented Soymilk on the Gut Microbiota by In Vitro Fecal Fermentation | |
CN109913526A (zh) | 微生物在鉴别和/或区分不同种族个体中的应用 | |
Harshavardhana et al. | High sugar induced changes in gut microflora in Drosophila melanogaster: Protective role of Gymnema sylvestre | |
Zhang et al. | Composition and diversity of Canidae fecal flora |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Lu Zhengqi Inventor after: Lu Yongjun Inventor after: Zhang Zhao Inventor after: Chen Tao Inventor after: Lei Chunyan Inventor after: Xu Ganlin Inventor before: Lei Chunyan Inventor before: Chen Tao Inventor before: Lu Zhengqi Inventor before: Lu Yongjun Inventor before: Xu Ganlin Inventor before: Zhang Zhao |
|
CB03 | Change of inventor or designer information |